Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Blood Advances|June 9, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamabAllison M Bock, Lei Feng, Ayushi Chauhan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Lisa S Gagne, et al.
Blood Advances|September 2, 2022
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphomaJeremy S Abramson, Elizabeth Bengston, Robert Redd, et al.
Blood|July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2016
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for LymphomaNatasha Kekre, Francisco J Marquez-Malaver, Monica Cabrero, et al.
Transplantation and Cellular Therapy|May 4, 2021
Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host DiseaseZhonghui K Luo, Edgar A Domenech-Estarellas, Amy Han, et al.
Blood|September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphomaPhilippe Armand, Ann Janssens, Giuseppe Gritti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2015
Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantationBrandon K C Au, Ted A Gooley, Philippe Armand, et al.
Leukemia & Lymphoma|December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplantAndrew A Lane, Philippe Armand, Yang Feng, et al.
Pageof 27